2,177 followers
First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis https://t.co/jmHO9MT6WS
First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis https://t.co/jmHO9MT6WS
New article: First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis https://t.co/SpXUTwsoEY #colorectalcancer #oncology https://t.co/5Ctlgh9IxB